Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
Teladoc Health (NYSE:TDOC) has announced the issuance of inducement awards to five new employees. Four employees from the recently acquired Uplift Health Technologies received restricted stock units totaling 215,028 shares, vesting over two or three years based on continued service. Additionally, a new non-executive employee was granted 52,300 restricted stock units, with one-third vesting on the first anniversary and the remainder vesting quarterly over two years.
These awards were approved by Teladoc's Compensation Committee under the company's 2023 Employment Inducement Incentive Award Plan, complying with NYSE Rule 303A.08.
Teladoc Health (NYSE:TDOC) ha annunciato l'assegnazione di premi di incentivazione a cinque nuovi dipendenti. Quattro dipendenti della recentemente acquisita Uplift Health Technologies hanno ricevuto unità di azioni vincolate per un totale di 215.028 azioni, con maturazione in due o tre anni in base alla permanenza nel servizio. Inoltre, un nuovo dipendente non esecutivo ha ottenuto 52.300 unità di azioni vincolate, con un terzo che matura al primo anniversario e il resto che matura trimestralmente nel corso di due anni.
Questi premi sono stati approvati dal Comitato per la Remunerazione di Teladoc nell’ambito del piano di incentivi per l’assunzione 2023 dell’azienda, in conformità con la Regola 303A.08 della NYSE.
Teladoc Health (NYSE:TDOC) ha anunciado la concesión de premios de incentivo a cinco nuevos empleados. Cuatro empleados de la recientemente adquirida Uplift Health Technologies recibieron unidades restringidas de acciones por un total de 215,028 acciones, que se consolidan en dos o tres años según la continuidad en el servicio. Además, un nuevo empleado no ejecutivo recibió 52,300 unidades restringidas de acciones, con un tercio consolidándose en el primer aniversario y el resto consolidándose trimestralmente durante dos años.
Estos premios fueron aprobados por el Comité de Compensación de Teladoc bajo el Plan de Incentivos por Contratación 2023 de la empresa, cumpliendo con la Regla 303A.08 de la NYSE.
Teladoc Health (NYSE:TDOC)는 다섯 명의 신입 직원에게 유인 보상을 발행했다고 발표했습니다. 최근 인수한 Uplift Health Technologies의 네 명의 직원은 총 215,028주의 제한 주식 단위를 받았으며, 계속 근무 시 2년 또는 3년에 걸쳐 권리가 취득됩니다. 또한 비임원 신입 직원 한 명에게는 52,300주의 제한 주식 단위가 부여되었으며, 1/3은 첫 번째 기념일에 권리가 부여되고 나머지는 2년에 걸쳐 분기별로 권리가 부여됩니다.
이 보상은 Teladoc의 보상 위원회에서 회사의 2023년 고용 유인 인센티브 상 계획에 따라 승인되었으며, NYSE 규칙 303A.08을 준수합니다.
Teladoc Health (NYSE:TDOC) a annoncé l’attribution de primes d’incitation à cinq nouveaux employés. Quatre employés de la société récemment acquise Uplift Health Technologies ont reçu des unités d’actions restreintes totalisant 215 028 actions, acquises sur deux ou trois ans sous réserve de la poursuite du service. De plus, un nouvel employé non cadre a obtenu 52 300 unités d’actions restreintes, un tiers étant acquis à la première année d’ancienneté et le reste trimestriellement sur deux ans.
Ces primes ont été approuvées par le comité de rémunération de Teladoc dans le cadre du Plan d’incitation à l’embauche 2023 de l’entreprise, en conformité avec la règle 303A.08 de la NYSE.
Teladoc Health (NYSE:TDOC) hat die Gewährung von Anreizprämien an fünf neue Mitarbeiter bekannt gegeben. Vier Mitarbeiter der kürzlich übernommenen Uplift Health Technologies erhielten Restricted Stock Units in Höhe von insgesamt 215.028 Aktien, die über zwei oder drei Jahre mit fortgesetzter Dienstzeit vesten. Zusätzlich erhielt ein neuer nicht-exekutiver Mitarbeiter 52.300 Restricted Stock Units, von denen ein Drittel am ersten Jahrestag vestet und der Rest vierteljährlich über zwei Jahre.
Diese Prämien wurden vom Vergütungsausschuss von Teladoc im Rahmen des Anreizplans für Neueinstellungen 2023 des Unternehmens genehmigt und entsprechen der NYSE-Regel 303A.08.
- Successful acquisition of Uplift Health Technologies, expanding company capabilities
- Retention strategy in place through restricted stock units for key acquired talent
- Structured vesting schedule promotes long-term employee commitment
- Stock-based compensation will lead to shareholder dilution
- Additional 267,328 shares to be issued, increasing outstanding shares
PURCHASE, N.Y., May 02, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to five new employees.
Effective April 30, 2025, in connection with the acquisition of Uplift Health Technologies, Inc., four employees of Uplift Health were granted awards of restricted stock units covering an aggregate of 215,028 shares of Teladoc Health’s common stock, par value
Also, effective May 1, 2025, in connection with commencing employment, an additional new non-executive employee of Teladoc Health was granted an award of restricted stock units covering 52,300 shares of Common Stock. The restricted stock units vest, based on continued service to Teladoc Health, as to one-third of the underlying shares on the first anniversary of the grant date, with the remainder vesting quarterly over two years thereafter.
The awards were approved by the Compensation Committee of the Board of Directors of Teladoc Health and were granted under the Teladoc Health, Inc. 2023 Employment Inducement Incentive Award Plan as employment inducement awards pursuant to New York Stock Exchange Rule 303A.08.
About Teladoc Health
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Teladoc Health leverages more than two decades of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit www.teladochealth.com.
Media:
Lou Serio
202-569-9715
PR@teladochealth.com
FAQ
How many shares of restricted stock units did Teladoc Health (TDOC) issue in May 2025?
What is the vesting schedule for TDOC's inducement awards issued in May 2025?
Why did Teladoc Health (TDOC) issue inducement awards in May 2025?
When were the Teladoc Health (TDOC) inducement awards approved and under what plan?
